Herold Advisors, Inc. Eli Lilly & CO Transaction History
Herold Advisors, Inc.
- $449 Million
- Q3 2024
A detailed history of Herold Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Herold Advisors, Inc. holds 11,362 shares of LLY stock, worth $9.98 Million. This represents 2.24% of its overall portfolio holdings.
Number of Shares
11,362
Previous 11,656
2.52%
Holding current value
$9.98 Million
Previous $10.6 Million
4.61%
% of portfolio
2.24%
Previous 2.49%
Shares
12 transactions
Others Institutions Holding LLY
# of Institutions
4,121Shares Held
740MCall Options Held
8.26MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$85.1 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$64.8 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$57.8 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$45.1 Billion26.72% of portfolio
-
State Street Corp Boston, MA33.9MShares$29.7 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $835B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...